Aoki T, Kaneta M, Onagi H, Morikawa J, Tsubota N, Watabe H
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Japan.
Biochem Mol Biol Int. 1996 Jun;39(3):461-9. doi: 10.1080/15216549600201511.
A recombinant human neuron-specific enolase (R-NSE), isolated from Escherichia coli, could not be used in an RIA system because of instability upon labeling. To apply R-NSE to RIA and to simplify the purification procedure, the N- and C-terminals of R-NSE were modified by tyrosine- and histidine-tagging, respectively. SY-NSE, containing one additional tyrosine residue, was obtained from both soluble and insoluble fractions. More derivatives tagged by two or four tyrosine residues were expressed, but only in the insoluble fraction. SY-NSE and SY-NSE.H6 (containing six histidine residues at C-terminal of SY-NSE) purified from the soluble fraction were applicable to the RIA system, indicating that the addition of a tyrosine residue at the terminal is effective if the antigen is unstable during labeling.
从大肠杆菌中分离出的重组人神经元特异性烯醇化酶(R-NSE),由于标记时不稳定,不能用于放射免疫分析(RIA)系统。为了将R-NSE应用于RIA并简化纯化程序,分别通过酪氨酸标记和组氨酸标记对R-NSE的N端和C端进行了修饰。含有一个额外酪氨酸残基的SY-NSE可从可溶性和不溶性部分获得。表达了更多带有两个或四个酪氨酸残基标记的衍生物,但仅存在于不溶性部分。从可溶性部分纯化的SY-NSE和SY-NSE.H6(在SY-NSE的C端含有六个组氨酸残基)适用于RIA系统,这表明如果抗原在标记过程中不稳定,在末端添加一个酪氨酸残基是有效的。